References

Arai K, Lo EH . Oligovascular signaling in white matter stroke. Biol Pharm Bull 2009; 32: 1639–44.
Leonardo P, Garcia JH, Gutierrez JA . Cerebral white matter is highly vulnerable to ischemia. Stroke 1996; 27: 1641–6.
Skoff RP, Bessert DA, Barks JD, Song D, Cerghet M, Silverstein FS . Hypoxic-ischemic injury results in acute disruption of myelin gene expression and death of oligodendroglial precursors in neonatal mice. Int J Devl Neurosci 2001; 19: 197–208.
Mekhail M, Almazan G, Tabrizian M . Oligodendrocyte-protection and remyelination post-spinal cord injuries: a review. Prog Neurobiol 2012; 96: 322–39.
Imai H, Masayasu H, Dewar D, Graham DI, Macrae IM . Ebselen protects both gray and white matter in a rodent model of focal cerebral ischemia. Stroke 2001; 32: 2149–54.
Guimarães JS, Freire MA, Lima RR, Picanço-Diniz CW, Pereira A, Gomes-Leal W . Minocycline treatment reduces white matter damage after excitotoxic striatal injury. Brain Res 2010; 1329: 182–93.
Klein C, Kramer EM, Cardine AM, Schraven B, Brandt R, Trotter J . Process outgrowth of oligodendrocytes is promoted by interaction of fyn kinase with the cytoskeletal protein tau. J Neurosci 2002; 22: 698–707.
Nishiyama A, Komitova M, Suzuki R, Zhu X . Polydendrocytes (NG2 cells): multifunctional cells with lineage plasticity. Nat Rev Neurosci 2009; 1: 9–22.
Mangin JM, Gallo V . The curious case of NG2 cells: transient trend or game changer? ASN Neuro 2011; 3: e00052.
Hillard CJ . Role of cannabinoids and endocannabinoids in cerebral ischemia. Curr Pharm Des 2008; 23: 2347–61.
Koizumi J, Yoshida Y, Nakazawa T, Ooneda G . Experimental studies of ischemic brain edema: 1. A new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area. Jpn Stroke J 1986; 8: 1–8.
Longa EZ, Weinstein PR, Carlson S, Cummins R . Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989; 20: 84–91.
Ulrich D and Group, Members on the MCAO-SOP. Standard operating procedures (SOP) in experimental stroke research: SOP for middle cerebral artery occlusion in the mouse. Available from Nature Precedings <https://www.carmenthyssenmalaga.org (2009).
Wojtowicz JM, Kee N . BrdU assay for neurogenesis in rodents. Nat Protoc 2006; 3: 1399–405.
Leker RR, Gai N, Mechoulam R, Ovadia H . Drug-induced hypothermia reduces ischemic damage: effects of the cannabinoid HU–210. Stroke 2003; 34: 2000–6.
Oida Y, Hamanaka J, Hyakkoku K, Shimazawa M, Kudo T, Imaizumi K, et al. Post-treatment of a BiP inducer prevents cell death after middle cerebral artery occlusion in mice. Neurosci Lett 2010; 484: 43–6.
Kramer M, Dang J, Baertling F, Denecke B, Clarner T, Kirsch C, et al. TTC staining of damaged brain areas after MCA occlusion in the rat does not constrict quantitative gene and protein analyses. J Neurosci Methods 2010; 187: 84–9.
Benjamin DH, Theo DP, Gary KS . Neurogenesis in rats after focal cerebral ischemia is enhanced by indomethacin. Stroke 2005; 36: 2718–24.
Solbrig MV, Fan Y, Hermanowicz N, Morgese MG, Giuffrida A . A synthetic cannabinoid agonist promotes oligodendrogliogenesis during viral encephalitis in rats. Exp Neurol 2010; 226: 231–41.
Hu B, Wang Q, Chen Y, Du J, Zhu X, Lu Y, et al. Neuroprotective effect of WIN55,212-2 pretreatment against focal cerebral ischemia through activation of extracellular signal-regulated kinases in rats. Eur J Pharmacol 2010; 645: 102–7.
Taupin P . BrdU immunohistochemistry for studying adult neurogenesis: Paradigms, pitfalls, limitations, and validation. Brain Res Rev 2007; 1: 198–214.
Zhang L, Michael C, Ruilan Z, Lei W, Jing Z, Ying W . Erythropoietin amplifies stroke-induced oligodendrogenesis in the rat. PloS One 2010; 6: e11016.
Anke P, Nadine J, Otto WW, Christiane F . Identification of ischemic regions in a rat model of stroke. PLoS One 2009; 4: e4764.
McMahon LR . Characterization of cannabinoid agonists and apparent p A 2 analysis of cannabinoid antagonists in rhesus monkeys discriminating Delta9-tetrahydrocannabinol. J Pharmacol Exp Ther 2006; 319: 1211–8.
Ken A, Eng HL . Experimental models for analysis of oligodendrocyte pathophysiology in stroke